NCT00061035View on ClinicalTrials.gov

Evaluation of Transgenic Lymphocyte Immunization Vaccine in Subjects With Prostate Adenocarcinoma

PHASE1CompletedINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

April 30, 2003

Conditions

Prostatic Neoplasms

Interventions

BIOLOGICAL

Transgenic Lymphocyte Immunization Vaccine (TLI)

Trial Locations (1)

92093-0987

University of California, San Diego Cancer Center, San Diego

Sponsors

Lead Sponsor

Cosmo Bioscience

All Listed Sponsors

lead

Cosmo Bioscience

INDUSTRY

NCT00061035 - Evaluation of Transgenic Lymphocyte Immunization Vaccine in Subjects With Prostate Adenocarcinoma | Biotech Hunter | Biotech Hunter